AWARDS
CHARACTERISING THE PROTEOGENOME OF CIRCULATING TUMOUR CELLS
A Science Foundation Ireland funded award valued at €79,965, Award code: 18/IF/6329. This award funded an SFI Industry fellowship position in collaboration with industry partner Becton Dickinson (BD). The project entitled Characterising the proteogenome of Circulating Tumour Cells (CTCs) examined the utilised BD's Rhapsody single cell multiomic sequencing technology to explore the role of platelet cloaking and its therapeutic targeting using Aspirin in Cancer Metastasis using MDA-MB-231 breast cancer cells grown in 2D and 3D culture as models of CTCs and CTC clusters.
​
MULTIPLEX PROFILING OF OESOPHAGEAL ADENOCARCINOMA SERUM SAMPLES
An Irish Association for Cancer Research (IACR) award from the association of Irish floral artists (AOIFA) valued at €6000. This seed funding award was awarded to me by AOIFA at the 2019 IACR conference in Belfast to examine the role of a large number of pro-inflammatory mediators, chemokines, cytokines, angiogenic factors and markers of vascular function in a cohort of Oesophageal adenocarcinoma (OAC) patients using the 54 marker V-Plex ELISA technology from MSD .
SENESCENCE: A TARGET FOR DISRUPTION IN OVARIAN CANCER
This project valued at €3000 awarded by the Irish Cancer Society as part of their Translational Research Summer Studentship programme funded a 3-month studnet project examining the potential of Metformin to target induced senescence cancer cells which are a source of therapeutic resistance to paclitaxel therapy.
DELIVERING TOMORROW'S DIAGNOSTICS TODAY
An Enterprise Ireland funded €550,000 grant to establish a new genetic testing facility in conjunction with Industry collaborator Eurofins Biomnis.
